TFF Pharmaceuticals, Inc. (TFFP) is a publicly traded company in the Unknown sector. Across all available filings, 15 corporate insiders have executed 103 transactions totaling $40.0M, demonstrating a bearish sentiment with -$29.2M in net insider flow. The most recent transaction on Jul 3, 2024 involved a transaction of 1,583 shares valued at $0.
No significant insider buying has been recorded for TFFP in the recent period.
No significant insider selling has been recorded for TFFP in the recent period.
Based on recent SEC filings, insider sentiment for TFFP is bearish with an Insider Alignment Score of 13/100 and a net flow of -$29.2M. Insiders are reducing their positions, though this can be driven by factors unrelated to company outlook.
Insider trading at TFF Pharmaceuticals, Inc. (TFFP) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 15 insiders are actively trading TFFP stock, having executed 103 transactions in the past 90 days. The most active insider is Therapeutics, Inc. Lung (Executive), who has made 4 transactions totaling $24.6M.
Get notified when executives and directors at TFFP file new Form 4 transactions
Date | Insider | Title | Type | Shares | Price | Value | Flags |
|---|---|---|---|---|---|---|---|
| Jul 3, 2024 | Braxton King Thomas | Executive | Award | 1,583 | $N/A | $0 | |
| Jul 3, 2024 | Rocamboli Stephen | Executive | Award | 3,165 | $N/A | $0 | |
| Jul 3, 2024 | Mikhak Zamaneh | Executive | Award | 10,184 | $N/A | $0 | |
| Jul 3, 2024 | Allen Coleman Kirk | Executive | Award | 10,184 | $N/A | $0 | |
| Jul 3, 2024 | Roberts Brandi | Executive | Award | 3,165 | $N/A | $0 | |
| Jul 3, 2024 | S. Mills Robert | Executive | Award | 3,165 | $N/A | $0 | |
| Jul 3, 2024 | Chai-zon Lee Catherine | Executive | Award | 1,583 | $N/A | $0 | |
| Jul 3, 2024 | F. Weisman Harlan | Executive | Award | 27,480 | $N/A | $0 | |
| Aug 16, 2023 | Duane Carlson Clint | Executive | Sale | 1,000 | $0.39 | $390 | |
| Aug 15, 2023 | Mikhak Zamaneh | Executive | Purchase | 120,000 | $0.25 | $30.0K | |
| Aug 15, 2023 | Allen Coleman Kirk | Executive | Purchase | 20,000 | $0.25 | $5.0K | |
| Aug 15, 2023 | S. Mills Robert | Executive | Purchase | 40,000 | $0.25 | $10.0K | |
| Aug 15, 2023 | Roberts Brandi | Executive | Purchase | 20,000 | $0.25 | $5.0K | |
| Aug 15, 2023 | Rocamboli Stephen | Executive | Purchase | 20,000 | $0.25 | $5.0K | |
| Aug 15, 2023 | F. Weisman Harlan | Executive | Purchase | 600,000 | $0.25 | $150.0K |
| TYPE | COUNT | VALUE | % |
|---|---|---|---|
Sale(S) | 30 | $34.6M | 83.6% |
Purchase(P) | 42 | $5.4M | 13.0% |
Exercise(M) | 21 | $1.4M | 3.4% |
Award(A) | 8 | $0 | 0.0% |
Conversion(C) | 2 | $0 | 0.0% |
Insider selling pressure at TFF Pharmaceuticals, Inc. has increased, with 15 insiders executing 103 transactions across all time. Total sales of $34.6M significantly outpace purchases of $5.4M, resulting in a net outflow of $29.2M. This selling activity appears largely discretionary, which may warrant closer attention from investors.